No CDSCO panel nod to Dr Reddys for Sputnik V yet, additional data sought Ruchika Sharma2 April 2021 1:01 PM ISTSputnik V has demonstrated an efficacy rate of 91.6 per cent in the interim analysis of phase 3 clinical trial, which included data on 19,866...
CDSCO panel to decide on emergency use of Sputnik V today Ruchika Sharma31 March 2021 3:10 PM ISTNew Delhi: Meeting of Subject Expert Committee (SEC) of the Central Drugs Standard Control Organisation (CDSCO) will be held on Wednesday to...
Indian regulator nod for Sputnik V expected in next few weeks: Dr Reddys Ruchika Sharma30 March 2021 1:28 PM ISTObserving that trials of the vaccine have been conducted in Russia, India, the UAE and others, Sapra said the vaccine demonstrated an efficacy of 91.6...
Dr Reddy's labs gets USFDA 3 observations for New York API facility Ruchika Sharma11 March 2021 12:21 PM ISTNew Delhi: Dr Reddy's Laboratories on Wednesday said the US health regulator has issued a Form 483 with three observations after inspecting its...
Sputnik V could be third COVID-19 vaccine for India: Experts MD Bureau7 March 2021 9:15 AM ISTNew Delhi: To cater to the vaccination process of the world's largest democracy, it would be pertinent to bring in safer and more effective...
Realisation there in pharma industry to become self reliant in API production: IPA Ruchika Sharma26 Feb 2021 9:00 AM ISTJain however noted that it will take some time for the country to get self reliance in API production.
Dr Reddy's Labs launches Lansoprazole DR Orally Disintegrating Tablets in US Ruchika Sharma22 Feb 2021 3:14 PM ISTHyderabad and Princeton: Dr. Reddy's Laboratories Ltd. today announced the launch of Lansoprazole DR Orally Disintegrating Tablets...
Dr Reddy's labs begins Sputnik V Emergency Use Authorization process Ruchika Sharma20 Feb 2021 1:28 PM ISTSputnik V maintained a consistent efficacy at 91.8% even among the group of 2, 144 volunteers over 60 year old.
Dr Reddy's Labs launches generic Prolixin tablets in US Ruchika Sharma19 Feb 2021 12:08 PM ISTHyderabad and Princeton: Drug major, Dr. Reddy's Laboratories Ltd., has recently announced the launch of Fluphenazine Hydrochloride Tablets,...
Dr. Reddys unveils Vigabatrin Tablets to treat complex partial seizures in US Ruchika Sharma3 Feb 2021 12:14 PM ISTHyderabad and Princeton: Drug major, Dr. Reddy's Laboratories Ltd., has recently announced the launch of Vigabatrin Tablets USP, 500 mg in the...
Bharat Biotech welcomes budget allocation of Rs 35000 crore for Covid vaccine Ruchika Sharma2 Feb 2021 12:36 PM ISTHyderabad: Covaxin maker Bharat Biotech on Monday described as "far reaching" initiative the allocation of Rs 35,000 crore for Covid-19 vaccination in...
Dr Reddys likely to launch Sputnik V in India in March MD Bureau31 Jan 2021 11:00 AM ISTHyderabad: Dr Reddy's Laboratories Ltd hopes to launch Russian Covid vaccine Sputnik V in India in March after obtaining Emergency Use...
